Delisting risk
PTIX · NASDAQ · Biotechnology

Protagenic Therapeutics (PTIX)

Developing PT00114 for stress-related neuropsychiatric disorders.

$1.15
At close−0.04 (−3.36%)

Breakdown13F · 13D/G · Form 4

Institutions4 holders · as of Mar 31, 20263.70%66.9K shares
Insiders2 holders · as of Aug 24, 20264.96%89.8K shares
Otherremainder91.34%1.65M shares

1.81M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Garo H. ArmenInsiderdirector, officer: EXEC. CHAIR & PRINCIPAL OFF
4.06%73,533Form 4filed Aug 24, 2026
DRW Securities, LLCInstitution
2.31%41,78313Fas of Mar 31, 2026
FNY Investment Advisers, LLCInstitution
1.38%25,00013Fas of Mar 31, 2026
Barrett EvansInsiderdirector, 10 percent owner, officer: ex CEO
0.90%16,233Form 4filed Oct 24, 2025
Corecap Advisors, LLCInstitution
0.01%10013Fas of Mar 31, 2026
United Financial Planning Group LLCInstitution
0.00%1713Fas of Mar 31, 2026
Hudson Bay Capital Management, L.P.Institution
9.99% of class, as filed13G/Afiled Jan 30, 2017
of the Act (however, see the Notes).Insider
9.99% of class, as filed13G/Afiled Feb 10, 2021
Khalil Barrage1Insiderdirector
0.40%7,321Form 4filed May 5, 2021
Alexander K. Arrow2Insiderofficer: Chief Financial Officer
0.18%3,273Form 4filed Oct 13, 2023
  1. Last filed May 5, 2021; leaving the company requires no filing. Not in the bar.
  2. Last filed Oct 13, 2023; leaving the company requires no filing. Not in the bar.

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

4 holders · 66.9K shares · 1 new position · 1 increased · 1 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
DRW Securities, LLC41.8K2.31%−1.1KMay 13, 2026
FNY Investment Advisers, LLC25.0K1.38%0Apr 15, 2026
Corecap Advisors, LLC1000.01%+100newApr 7, 2026
United Financial Planning Group LLC170.00%0May 8, 2026

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 21, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase20,000$0.650073,533
Aug 20, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase16,634$0.589853,533
Aug 19, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase2,700$0.350036,899
Aug 11, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase2,220$0.320034,199
Aug 6, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase685$0.220031,979
Aug 5, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF
Purchase5,000$0.258831,294
Jul 30, 2026
Garo H. Armendirector, officer: EXEC. CHAIR & PRINCIPAL OFF.
Purchase26,291$0.182826,291

CongressHouse and Senate disclosures

Not reported.